Literature DB >> 3049090

Angiotensin converting enzyme inhibitors and ischaemic heart disease.

G Ertl1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3049090     DOI: 10.1093/eurheartj/9.7.716

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

Review 1.  Cardiovascular drugs.

Authors:  P Vermeij
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

2.  The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig.

Authors:  R A Tio; C D de Langen; P A de Graeff; W H van Gilst; K J Bel; K G Wolters; P H Mook; J van Wijngaarden; H Wesseling
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

Review 3.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 4.  Angiotensin converting enzyme inhibitors in angina and myocardial infarction. What role will they play in the 1990s?

Authors:  G Ertl
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 5.  Perindopril. A review of its pharmacokinetics and clinical pharmacology.

Authors:  R J Macfadyen; K R Lees; J L Reid
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 6.  Cardiovascular therapies in the 1990s. An overview.

Authors:  R C Becker; J M Gore
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

7.  Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril.

Authors:  Katarzyna A Mitręga; Adrianna M Spałek; Jerzy Nożyński; Maurycy Porc; Magdalena Stankiewicz; Tadeusz F Krzemiński
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.